The PF4/H antibody was effective for prediction of the risk of thrombosis , except in patients with dysfunctional platelets ; aspirin manifested effects similar to clopidogrel in terms of prevention of thromboses in PF4/H antibody-positive patients , but costs much less and is therefore recommended .